OpenVSafe by OpenVAERS
Search V-safe

TYR-97835-59752

3 vaccinations 5 coded responses 11 check-ins 5 free-text entries 4 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
906 / CA
Registered
2020-12-23
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2020-12-23
    Registered in v-safe
  2. 2020-12-23
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-23
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · None
    Adult check-in
  4. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  5. 2021-01-01
    Survey response — day 7, dose 1
    MedDRA: Ageusia, Anosmia, COVID-19 — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Systemic reaction (other): Loss of taste and smell · Healthcare visit (other): Diagnosed with COVID on 12/31/20
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-01-01
    Report sent to call center — day 7, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  7. 2021-01-06
    Survey response — day 14, dose 1
    MedDRA: Ageusia, Anosmia, Chest pain, Dyspnoea, Nasal congestion — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Loss of tasteLoss of smellExtreme nasal congestionOccasional chest pain and shortness of breath
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-06
    Report sent to call center — day 14, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  9. 2021-01-21
    Dose 2 — Pfizer-BioNTech
  10. 2021-01-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  11. 2021-01-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  12. 2021-01-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  13. 2021-01-26
  14. 2021-02-04
    Survey response — day 14, dose 2
    MedDRA: Headache, Nausea — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities
    Free text: HeadachesNausea
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-18
    Survey response — day 28, dose 2
    MedDRA: Dizziness, Fatigue, Headache, Pain — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Really bad headachesDizzinessFatigueBody aches
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-18
    Report sent to call center — day 28, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  17. 2021-07-22
    Survey response — 6 months, dose 2
    MedDRA: Back pain, Myalgia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Muscular pain in back and stomach
    MedDRA releases: 2024-11 · check-in free text available
  18. 2021-07-22
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  19. 2021-07-23
  20. 2021-10-04
    Dose 3 — Pfizer-BioNTech
  21. 2022-01-21
    Health check-in — 12 months, dose 2
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-23Pfizer-BioNTech
22021-01-21Pfizer-BioNTech
32021-10-04Pfizer-BioNTech No

Call center

4 call center cases

4 unsuccessful

See the call center timeline

Free text

Release 1 — day 7, dose 1

2021-01-01

Systemic reaction (other): Loss of taste and smell
Healthcare visit (other): Diagnosed with COVID on 12/31/20

Release 1 — day 14, dose 1

2021-01-06

Symptoms: Loss of tasteLoss of smellExtreme nasal congestionOccasional chest pain and shortness of breath

Release 3 — day 14, dose 2

2021-02-04

Symptoms: HeadachesNausea

Release 4 — day 28, dose 2

2021-02-18

Symptoms: Really bad headachesDizzinessFatigueBody aches

Release 9 — 6 months, dose 2

2021-07-22

Symptoms: Muscular pain in back and stomach

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOCOVID-19 ✓ ✓ ✓
SDAgeusia ✓ ✓ ✓
SDAnosmia ✓ ✓ ✓
SDBack pain · · ✓
SDChest pain ✓ ✓ ✓
SDDizziness ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDMyalgia · · ✓
SDNasal congestion ✓ ✓ ✓
SDNausea ✓ ✓ ✓
SDPain ✓ ✓ ✓
SROAgeusia ✓ ✓ ✓
SROAnosmia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release